| Primary |
| Urinary Tract Infection |
25.9% |
| Infection |
12.7% |
| Cellulitis |
7.5% |
| Product Used For Unknown Indication |
7.5% |
| Sinusitis |
5.5% |
| Staphylococcal Infection |
4.5% |
| Drug Use For Unknown Indication |
4.3% |
| Hypertension |
4.2% |
| Prophylaxis |
3.8% |
| Pneumocystis Jiroveci Pneumonia |
3.2% |
| Prostatitis |
2.8% |
| Antifungal Prophylaxis |
2.5% |
| Upper Respiratory Tract Infection |
2.5% |
| Infection Prophylaxis |
2.3% |
| Acne |
2.2% |
| Cystitis |
2.0% |
| Hiv Infection |
1.8% |
| Pneumonia |
1.7% |
| Ear Infection |
1.5% |
| Pyrexia |
1.5% |
|
| Renal Failure Acute |
18.7% |
| Rash |
12.1% |
| Urticaria |
10.3% |
| Vomiting |
8.4% |
| Stevens-johnson Syndrome |
7.6% |
| Hyperkalaemia |
7.4% |
| Pyrexia |
4.2% |
| Thrombocytopenia |
3.4% |
| Angioedema |
2.9% |
| Tremor |
2.9% |
| Tubulointerstitial Nephritis |
2.9% |
| Acute Febrile Neutrophilic Dermatosis |
2.6% |
| Drug Hypersensitivity |
2.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.4% |
| Pancytopenia |
2.4% |
| Pruritus |
2.1% |
| Rash Generalised |
2.1% |
| Renal Failure |
2.1% |
| Blood Urea Increased |
1.6% |
| Rash Pruritic |
1.6% |
|
| Secondary |
| Hiv Infection |
17.0% |
| Drug Use For Unknown Indication |
15.6% |
| Prophylaxis |
12.1% |
| Product Used For Unknown Indication |
10.8% |
| Rheumatoid Arthritis |
6.0% |
| Antifungal Prophylaxis |
4.5% |
| Infection Prophylaxis |
3.2% |
| Prophylaxis Against Transplant Rejection |
3.1% |
| Pneumonia |
3.1% |
| Hypertension |
3.1% |
| Pneumocystis Jiroveci Pneumonia |
2.8% |
| Immunosuppression |
2.7% |
| Urinary Tract Infection |
2.3% |
| Interstitial Lung Disease |
2.2% |
| Multiple Myeloma |
2.2% |
| Whipple's Disease |
2.0% |
| Adult T-cell Lymphoma/leukaemia |
1.9% |
| Fungal Infection |
1.8% |
| Febrile Bone Marrow Aplasia |
1.8% |
| Diarrhoea |
1.5% |
|
| Vomiting |
11.1% |
| Pyrexia |
9.8% |
| Renal Failure Acute |
8.1% |
| Transplant Rejection |
6.4% |
| Septic Shock |
5.7% |
| Thrombocytopenia |
5.4% |
| Pruritus |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Toxic Epidermal Necrolysis |
5.1% |
| Pancytopenia |
4.4% |
| Renal Impairment |
4.4% |
| Neutropenia |
4.1% |
| Urinary Tract Infection |
4.1% |
| Completed Suicide |
3.4% |
| Cytomegalovirus Infection |
3.0% |
| Death |
3.0% |
| Liver Disorder |
3.0% |
| Pneumocystis Jiroveci Pneumonia |
3.0% |
| Tubulointerstitial Nephritis |
3.0% |
| Weight Decreased |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.1% |
| Prophylaxis |
14.5% |
| Drug Use For Unknown Indication |
14.0% |
| Hiv Infection |
9.7% |
| Rheumatoid Arthritis |
7.1% |
| Multiple Myeloma |
5.1% |
| Diffuse Large B-cell Lymphoma |
3.9% |
| Infection Prophylaxis |
3.6% |
| Antifungal Prophylaxis |
2.9% |
| Acne |
2.9% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Premedication |
2.3% |
| Hypertension |
2.3% |
| Prophylaxis Against Transplant Rejection |
2.1% |
| Pneumocystis Jiroveci Pneumonia |
1.7% |
| Antibiotic Prophylaxis |
1.7% |
| Renal Transplant |
1.7% |
| B-cell Lymphoma |
1.7% |
| Osteoporosis |
1.5% |
| Pneumonia |
1.5% |
|
| White Blood Cell Count Decreased |
14.6% |
| Pyrexia |
8.7% |
| Vomiting |
8.3% |
| Thrombocytopenia |
5.9% |
| Pneumonia |
5.8% |
| Deep Vein Thrombosis |
5.7% |
| Sepsis |
5.0% |
| Neutropenia |
4.6% |
| Weight Decreased |
4.6% |
| Platelet Count Decreased |
4.1% |
| Respiratory Failure |
4.1% |
| Febrile Neutropenia |
3.4% |
| Transplant Rejection |
3.4% |
| Pulmonary Embolism |
3.3% |
| Stomatitis |
3.2% |
| Tuberculosis |
3.2% |
| Cytomegalovirus Infection |
3.1% |
| Death |
3.1% |
| Renal Impairment |
3.1% |
| Interstitial Lung Disease |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
61.2% |
| Contraception |
4.7% |
| Convulsion |
4.7% |
| Transplant |
3.5% |
| Anxiety |
2.4% |
| Cystitis |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Nausea |
2.4% |
| Neutropenia |
2.4% |
| Petit Mal Epilepsy |
2.4% |
| Cytomegalovirus Infection |
1.2% |
| Dementia Alzheimer's Type |
1.2% |
| Enteritis |
1.2% |
| Gastric Disorder |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Metastatic Malignant Melanoma |
1.2% |
| Prophylaxis |
1.2% |
| Prophylaxis Urinary Tract Infection |
1.2% |
| Restless Legs Syndrome |
1.2% |
| Urinary Tract Infection |
1.2% |
|
| Unintended Pregnancy |
17.6% |
| Renal Tubular Necrosis |
11.8% |
| Cystitis |
5.9% |
| Drug Ineffective |
5.9% |
| Drug Interaction |
5.9% |
| Haemorrhage |
5.9% |
| Hyperkalaemia |
5.9% |
| Hyponatraemia |
5.9% |
| Inappropriate Antidiuretic Hormone Secretion |
5.9% |
| Lymphopenia |
5.9% |
| Myoclonus |
5.9% |
| Pyrexia |
5.9% |
| Respiratory Tract Haemorrhage |
5.9% |
| Urogenital Haemorrhage |
5.9% |
|
